論文

国際誌
2021年2月8日

Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.

Japanese journal of clinical oncology
  • Kobayashi Y
  • Hirasawa A
  • Chiyoda T
  • Ueki A
  • Masuda K
  • Misu K
  • Kawaida M
  • Hayashi S
  • Kataoka F
  • Banno K
  • Kosaki K
  • Aoki D
  • 全て表示

51
2
開始ページ
213
終了ページ
217
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1093/jjco/hyaa173
出版者・発行元
Japanese journal of clinical oncology

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com. BACKGROUND: Risk-reducing salpingo-oophorectomy is performed for the primary prevention of ovarian cancer in patients with hereditary breast-ovarian cancer syndrome. We performed risk-reducing salpingo-oophorectomy for the first time in Japan in 2008, and we experienced 20 cases of risk-reducing salpingo-oophorectomy through 2019. In the past, the use of risk-reducing salpingo-oophorectomy in Japan was restricted because it was not covered by a Japanese National Health Insurance. Since April 2020, risk-reducing salpingo-oophorectomy has been covered by insurance for patients with breast-ovarian cancer syndrome and pre-existing breast cancer, and this surgery is expected to become more widely implemented in Japan. METHODS: To contribute to the widespread use of risk-reducing salpingo-oophorectomy in the future, we retrospectively reviewed 20 cases of risk-reducing salpingo-oophorectomy at our hospital cohort study to clarify the issues in its implementation. RESULTS: The variant genes for which risk-reducing salpingo-oophorectomy was indicated were BRCA1 and BRCA2 in 13 (65%) and 7 patients (35%), respectively. The median age at which risk-reducing salpingo-oophorectomy was performed was 49 years (range, 38-58), 13 patients (65%) had gone through menopause, and 16 patients (80%) had a history of breast cancer. Of the five patients (25%) with vasomotor symptoms, four received Chinese medicine, and only one received hormone replacement therapy. Occult cancer was detected in the removed ovaries in two patients (10%), although no postoperative peritoneal carcinogenesis has been observed to date. CONCLUSIONS: Women who paid for risk-reducing salpingo-oophorectomy out of pocket were older than the recommended age at which the procedure should be performed, and this may explain the higher rate of occult cancers than previously reported. We need to perform risk-reducing salpingo-oophorectomy at the recommended age to ensure that the procedure is effective for primary prevention.

リンク情報
DOI
https://doi.org/10.1093/jjco/hyaa173
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33037428
URL
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102088898&origin=inward
ID情報
  • DOI : 10.1093/jjco/hyaa173
  • ISSN : 0368-2811
  • PubMed ID : 33037428

エクスポート
BibTeX RIS